ClinicalTrials.gg
RecruitingNCT07550270Updated Apr 24, 2026

Body Weight-Supported and Virtual Reality Gait Training in Stroke Patients

An interventional study of Virtual Reality-Assisted Gait Training and Backward Gait Training in Stroke, Walking Impairment and Balance, sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 45 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-04-24.

Sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
45 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 13 studies in Stroke by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital — 2 open to participants now, 2 under way, none of them phase 3. Stroke · Gaziler Physical Medicine and Rehabilitation Education and Research Hospital.

Started
2026
the only one that year
No phase
8 of 13
2 open now
Registered
13th of 13
by date

Among the 13 studies in Stroke by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital, this one is the only one that started in 2026, is one of 8 with no phase, and was the 13th registered.

By phase

13 studies; the count open now beside each. This study's row is marked.

No phasethis study8 · 2 open
Observational5 · 0 open

By the year they started

First in 2018; this study’s year is marked. 1 started in 2026.

Size and results

Median enrollment 35 across the 8 interventional studies, 44 across the 5 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 13 studies in Stroke by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital, or all of them as a file.
02

Study summary

The aim of this study is to compare the effects of body weight-supported gait training that includes virtual reality-assisted dual-task applications with body weight-supported forward and backward gait training on functional capacity, gait parameters (such as step length, gait speed, and balance), cognitive functions and psychological status in patients with stroke. The findings of this study are expected to contribute to the development of more effective rehabilitation strategies for improving mobility in patients with stroke

Read the detailed description

Stroke is a leading cause of disability worldwide and often results in motor, balance, and cognitive impairments that negatively affect functional independence and quality of life. Walking limitations are among the most common consequences after stroke and represent a major barrier to community participation. Therefore, improving gait performance and functional mobility is a primary goal of stroke rehabilitation.

Body weight-supported gait training is widely used to improve walking ability in individuals with impaired balance and reduced motor function. In recent years, rehabilitation technologies such as virtual reality-assisted gait training have been increasingly incorporated into clinical practice. Virtual reality may enhance patient engagement and promote both motor and cognitive recovery by providing interactive environments and increasing task demands.

Backward walking training has also gained attention as an alternative rehabilitation approach. Compared to forward walking, backward walking requires greater postural control and cognitive processing, similar to dual-task training, and may contribute to improvements in balance and gait performance. However, there is limited evidence directly comparing virtual reality-assisted dual-task gait training with backward walking training in patients with stroke.

This study aims to compare the effects of body weight-supported virtual reality-assisted dual-task gait training and body weight-supported forward and backward gait training on functional capacity, gait parameters, cognitive functions, and psychological status in patients with stroke. The findings of this study are expected to contribute to the development of more effective rehabilitation strategies for improving mobility and functional outcomes in stroke rehabilitation.

03

Conditions studied

  • Stroke
  • Walking Impairment
  • Balance
  • Gait Training

Browse trials for

Keywords

  • stroke
  • gait training
04

Who can participate

Ages eligible
45 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients experiencing their first-ever stroke
  • Patients with a post-stroke duration of more than 2 weeks
  • Patients with plantar flexor muscle spasticity of the lower extremity less than grade 3 according to the Modified Ashworth Scale (MAS)
  • Patients with a Brunnstrom stage of the lower extremity greater than 2
  • Patients who are able to stand independently or under supervision for at least 2 minutes for standing assessments
  • Patients who are able to walk at least 10 meters independently or under supervision, with or without an assistive device, for walking assessments
  • Patients with sufficient cognitive function to understand study instructions ( [MMSE] score > 23)
  • Patients with stable medical and psychological conditions
  • Patients who are willing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Patients with bilateral hemispheric lesions
  • Patients with severe cardiovascular or musculoskeletal conditions that prevent walking (e.g., fixed ankle contracture)
  • Patients using a permanent urinary catheter, or those with pressure ulcers or urinary and/or fecal incontinence
  • Patients with unilateral neglect
  • Patients with neurological conditions other than stroke that may affect balance performance (e.g., Parkinson's disease, epilepsy, meningitis, cerebellar disorders, vertigo, dizziness, polyneuropathy) or musculoskeletal disorders (e.g., severe low back pain, knee disorders)
  • Patients with severe visual, hearing, or speech impairments
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Virtual Reality-Assisted Forward Gait Training

    Participants in this group will receive conventional rehabilitation, including physiotherapy, occupational therapy, and speech, language, and swallowing therapy, for six weeks (five days per week, approximately 2-3 hours per day). In addition, participants will undergo body weight-supported virtual reality-assisted forward gait training with 30% body weight support for six weeks (five days per week, 30 minutes per day).

    Other: Virtual Reality-Assisted Gait Training

  • Experimental
    Backward Gait Training

    Participants in this group will receive conventional rehabilitation, including physiotherapy, occupational therapy, and speech, language, and swallowing therapy, for six weeks (five days per week, approximately 2-3 hours per day). In addition, participants will undergo body weight-supported backward gait training with 30% body weight support for six weeks (five days per week, 30 minutes per day).

    Other: Backward Gait Training

  • Experimental
    Forward Gait Training

    Participants in this group will receive conventional rehabilitation, including physiotherapy, occupational therapy, and speech, language, and swallowing therapy, for six weeks (five days per week, approximately 2-3 hours per day). In addition, participants will undergo body weight-supported forward gait training with 30% body weight support for six weeks (five days per week, 30 minutes per day).

    Other: Forward Gait Training

Interventions

  • OtherVirtual Reality-Assisted Gait Training

    Body weight-supported virtual reality-assisted forward gait training with 30% body weight support, applied five days per week for six weeks.

  • OtherBackward Gait Training

    Body weight-supported backward gait training with 30% body weight support, applied five days per week for six weeks.

  • OtherForward Gait Training

    Body weight-supported forward gait training with 30% body weight support, applied five days per week for six weeks.

06

What researchers measure

Primary outcomes

  1. 10-Meter Walk Test

    A measure used to assess patients' ambulation. During the test, the patient walks at a comfortable walking speed between two markers placed 10 meters apart, and the time required to complete the distance is recorded.

    Time frame: At baseline and after 6 weeks of intervention.

Secondary outcomes

  1. 6-Minute Walk Test (6MWT)

    A submaximal exercise test commonly used to assess functional capacity and response to treatment. During the test, participants are instructed to walk as far as possible within six minutes. The total distance walked is recorded as an indicator of cardiopulmonary capacity and exercise tolerance.

    Time frame: At baseline and after 6 weeks of intervention

  2. Fugl-Meyer Assessment - Lower Extremity Motor Subscale

    A standardized assessment used to evaluate sensorimotor impairment in individuals with stroke. The lower extremity motor subscale measures motor recovery and functional movement of the lower limb following stroke.

    Time frame: At baseline and after 6 weeks of intervention

  3. Functional Independence Measure (FIM)

    A widely used assessment tool for evaluating functional abilities in individuals undergoing rehabilitation. The scale assesses both motor and cognitive domains, including self-care, sphincter control, transfers, mobility, communication, and social interaction.

    Time frame: At baseline and after 6 weeks of intervention.

  4. Berg Balance Scale (BBS)

    A widely used clinical test for assessing static and dynamic balance abilities. The test consists of a series of functional balance tasks, each scored on a scale from 0 (unable) to 4 (independent), with the total score representing overall balance performance.

    Time frame: At baseline and after 6 weeks of intervention.

  5. Montreal Cognitive Assessment (MoCA)

    A brief cognitive screening tool used to assess cognitive functions, including memory, attention, language, visuospatial abilities, executive functions, calculation, and orientation. The test is scored on a 30-point scale, with higher scores indicating better cognitive performance.

    Time frame: At baseline and after 6 weeks of intervention.

  6. Stroke-Specific Quality of Life Scale (SS-QOL)

    A standardized measure used to assess health-related quality of life in individuals with stroke, covering physical, emotional, and social domains affected by the condition.

    Time frame: At baseline and after 6 weeks of intervention.

  7. Hospital Anxiety and Depression Scale (HADS)

    A 14-item self-report questionnaire designed to assess the presence and severity of anxiety and depression symptoms in clinical populations.

    Time frame: At baseline and after 6 weeks of intervention.

  8. Foot Rotation

    Gait analysis will be performed using the Zebris RehaWalk® system. Foot rotation (foot progression angle) quantifies the angular deviation of the foot relative to the direction of walking, measured in degrees.

    Time frame: At baseline and after 6 weeks of intervention.

  9. Step Width

    Gait analysis will be performed using the Zebris RehaWalk® system. Step width measures the mediolateral distance between the heel centers of consecutive footfalls during walking.

    Time frame: At baseline and after 6 weeks of intervention.

  10. Step Length

    Gait analysis will be performed using the Zebris RehaWalk® system. Step length measures the anteroposterior distance between the heel contact point of one foot and the heel contact point of the contralateral foot during walking.

    Time frame: At baseline and after 6 weeks of intervention.

  11. Stance Phase

    Gait analysis will be performed using the Zebris RehaWalk® system. Stance phase represents the percentage of the gait cycle during which the foot remains in contact with the ground.

    Time frame: At baseline and after 6 weeks of intervention.

  12. Swing Phase

    Gait analysis will be performed using the Zebris RehaWalk® system. Swing phase represents the percentage of the gait cycle during which the foot is off the ground.

    Time frame: At baseline and after 6 weeks of intervention.

  13. Double Stance

    Gait analysis will be performed using the Zebris RehaWalk® system. Double stance represents the percentage of the gait cycle during which both feet are simultaneously in contact with the ground.

    Time frame: At baseline and after 6 weeks of intervention.

  14. Gait Velocity

    Gait analysis will be performed using the Zebris RehaWalk® system. Gait velocity measures the distance covered per unit time during walking, with reduced speed being one of the most sensitive indicators of hemiparetic gait impairment post-stroke.

    Time frame: At baseline and after 6 weeks of intervention.

  15. Cadence

    Gait analysis will be performed using the Zebris RehaWalk® system. Cadence measures the number of steps taken per minute during walking, reflecting the temporal coordination of the gait cycle

    Time frame: At baseline and after 6 weeks of intervention.

  16. Maximum Plantar Pressure

    Gait analysis will be performed using the Zebris RehaWalk® system. Maximum plantar pressure measures the peak pressure exerted on the foot sole during the stance phase of gait.

    Time frame: At baseline and after 6 weeks of intervention.

  17. Center of Pressure, Lateral Symmetry

    Gait analysis will be performed using the Zebris RehaWalk® system. Center of Pressure (COP) Lateral Symmetry measures the mediolateral displacement of the center of pressure between the paretic and non-paretic limbs during walking, reported in millimeters.

    Time frame: At baseline and after 6 weeks of intervention.

07

Study locations

1 of 1 sites recruiting
  • Ankara, Çankaya, Türkiye (Türkiye), 06800 Gaziler Physical Medicine and Rehabilitation Training And Research Hospital
    Ankara, Çankaya 06800, Turkey (Türkiye)
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Nov 2026, 8 months after the start.

Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 8 months is below that.

Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2026
First posted
Apr 24, 2026
StartActual
Mar 26, 2026
Primary completionEst.
Nov 2026
CompletionEst.
Dec 2026
Last update
Apr 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07550270
Lead sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Responsible party
Tuğba Atan, MD (Tugba Atan, MD, Associate Professor, Gaziler Physical Medicine and Rehabilitation Education and Research Hospital) — Principal investigator
First posted
Apr 24, 2026
Start date
Mar 26, 2026
Primary completion
Nov 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Apr 24, 2026

Study contacts

Irem ERTORAN INAN, MD
Contact
irem.ertoran@gmail.com
03122912422
Tuğba ATAN, Associate Professor, MD
principal investigator · Gaziler Physical Medicine and Rehabilitation Training And Research Hospital
Bilge YILMAZ, Professor, MD
study chair · Gaziler Physical Medicine and Rehabilitation Training And Research Hospital
Eda GÜRÇAY, Professor, MD
study director · Gaziler Physical Medicine and Rehabilitation Training And Research Hospital
Engin KOYUNCU, Professor, MD
study director · Gaziler Physical Medicine and Rehabilitation Training And Research Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion